Clinical Trial Update: Dual Intravitreal Implantation of NT-501 Encapsulated Cell Therapy for Glaucoma [Phase 2]

View source ↗

Summary

This is an update on a Phase 2 trial evaluating dual intravitreal NT-501 encapsulated cell therapy for glaucoma, sponsored by Stanford University, with the stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma

Drugs mentioned

• NT-501 Encapsulated Cell Therapy

Snippet

Sponsor: Stanford University | Conditions: Glaucoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING